Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Receivables (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Receivables for 17 consecutive years, with $688.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 23.74% year-over-year to $688.0 million, compared with a TTM value of $688.0 million through Dec 2025, up 23.74%, and an annual FY2025 reading of $688.0 million, up 23.74% over the prior year.
  • Receivables was $688.0 million for Q4 2025 at Dentsply Sirona, up from $654.0 million in the prior quarter.
  • Across five years, Receivables topped out at $750.0 million in Q4 2021 and bottomed at $556.0 million in Q4 2024.
  • Average Receivables over 5 years is $659.0 million, with a median of $655.0 million recorded in 2024.
  • The sharpest move saw Receivables skyrocketed 35.55% in 2021, then fell 20.0% in 2024.
  • Year by year, Receivables stood at $750.0 million in 2021, then fell by 15.73% to $632.0 million in 2022, then increased by 9.97% to $695.0 million in 2023, then decreased by 20.0% to $556.0 million in 2024, then rose by 23.74% to $688.0 million in 2025.
  • Business Quant data shows Receivables for XRAY at $688.0 million in Q4 2025, $654.0 million in Q3 2025, and $646.0 million in Q2 2025.